ZIVO Bioscience, Inc. Share Price Other OTC
Equities
ZIVO
US98978N1019
Food Processing
Sales 2024 * | 5L 4.53Cr | Sales 2025 * | 15.08L 13Cr | Capitalization | 2.25Cr 186.57Cr |
---|---|---|---|---|---|
Net income 2024 * | -80L -66Cr | Net income 2025 * | -80L -66Cr | EV / Sales 2024 * | 41.2 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 14.9 x |
P/E ratio 2024 * |
-2.89
x | P/E ratio 2025 * |
-3.63
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 59.65% |
Managers | Title | Age | Since |
---|---|---|---|
John Payne
CEO | Chief Executive Officer | 76 | 19/13/19 |
Keith Marchiando
DFI | Director of Finance/CFO | 61 | 01/21/01 |
Laura Belicka
CTO | Chief Tech/Sci/R&D Officer | - | 01/21/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Nola Masterson
BRD | Director/Board Member | 77 | 17/14/17 |
Director/Board Member | 58 | 28/13/28 | |
John Payne
CEO | Chief Executive Officer | 76 | 19/13/19 |
1st Jan change | Capi. | |
---|---|---|
+13.97% | 820.31Cr | |
+5.29% | 761.21Cr | |
+0.60% | 595.4Cr | |
-6.04% | 372.06Cr | |
-10.75% | 356.97Cr | |
-7.53% | 127.17Cr | |
-29.55% | 107.47Cr | |
+14.57% | 99Cr | |
-12.85% | 89Cr |